Summary
The treatment of pain in the acute phase of a suspected acute myocardial infarction is often insufficient and has remained unchanged during recent years. The introduction of substances with a potential to limit the infarct size, such as thrombolysis and β-blockade, have, however, decreased the requirement for narcotic analgesics (which are still the drugs of choice in many hospitals). Knowledge is still lacking regarding the duration of pain relief, the time between drug administration and pain relief, and optimal doses for various analgesics. Future research should aim at the development of drugs with a more rapid onset of action, less side effects and more complete analgesia.
Similar content being viewed by others
References
Alderman EL. Analgesics in the acute phase of myocardial infarction. Journal of the American Medical Association 229: 1646–1648, 1974
Alderman EL, Barry WH, Graham AF, Harrison DC. Hemodynamic effects of morphine and pentazocine differ in cardiac patients. New England Journal of Medicine 287: 623–627, 1972
Anderson JL, Marshall HW, Askins JC, et al. A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction. Circulation 70: 606–618, 1984
Bondestam E, Hovgren K, Gaston Johansson F, et al. Pain assessment by patient and nurse in the early phase of acute myocardial infarction. Journal of Advanced Nursing 12: 677–682, 1987
Bressan MA, Costantini M, Klersy C, et al. Analgesic treatment in acute myocardial infarction: a comparison between indoprofen and morphine by a double-blind randomised pilot study. International Journal of Clinical Pharmacology, Therapy and Toxicology 23: 668–672, 1985
Davidsen O, Lindeneg O, Walsh M. Analgesic treatment with levomepromazine in acute myocardial infarction. Acta Medica Scandinavica 205: 191–194, 1979
GISSI (Gruppo Italiano per lo Studio della Streptochi-nasi nell’Infarto Miocardico). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 2: 871–874, 1987
Hayes MJ, Fraser AR, Hampton JR. Randomised trial comparing buprenorphine and diamorphine for chest pain in suspected acute myocardial infarction. British Medical Journal 2: 300–302, 1979
Herlitz J, Elmfeldt D, Hjalmarson Å, Holmberg S, Málek I, et al. Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarction. American Journal of Cardiology 51: 1282–1288, 1983
Herlitz J, Hjalmarson Å, Holmberg S, et al. Effect of metoprolol on chest pain in acute myocardial infarction. British Heart Journal 51: 438–444, 1984a
Herlitz J, Pennert K, Wedel H, et al. Tolerance. American Journal of Cardiology 53(13): 46D-50D, 1984b
Herlitz J, Richter A, Hjalmarson Å, et al. Variability of chest pain in suspected acute myocardial infarction according to subjective assessment and requirement of narcotic analgesics. International Journal of Cardiology 13: 9–22, 1986
International Collaborative Study Group. Reduction of infarct size with the early use of timolol in acute myocardial infarction. New England Journal of Medicine 310: 9–15, 1984
ISIS-1 Collaborative Group. A randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction. Lancet 2: 57–66, 1986
Kaplan K, Davidsson R, Parker M, et al. Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy. American Journal of Cardiology 51: 694–698, 1983
Kerr F, Donald KW. Analgesia in myocardial infarction. British Heart Journal 36: 117–121, 1974
Laffel GL, Braunwald E. Thrombolytic therapy. A new strategy for the treatment of acute myocardial infarction. First of two parts. New England Journal of Medicine 311: 710–717, 1984
Lasagna L, Beecher HK. The optimal dose of morphine. Journal of the American Medical Association 156: 230–234, 1954
Lee G, DeMaria AN, Amsterdam EA, et al. Comparative effects of morphine, meperidine and pentazocine on cardiocirculatory dynamics in patients with acute myocardial infarction. American Journal of Medicine 60: 949–955, 1976
Lis Y, Bennett D, Lambert G, Robson D. A preliminary double-blind study of intravenous nitroglycerin in acute myocardial infarction. Intensive Care Medicine 10: 179–184, 1984
Mannheimer C, Carlsson CA, Emanuelsson H, et al. The effects of transcutaneous electrical nerve stimulation in patients with severe angina pectoris. Circulation 71: 308–316, 1985
Maroko PR, Hillis LD, Muller JE, Tavazzi L, Heyndrickx GR, et al. Favorable effects of hyaluronidase on electrocardiographic evidence of necrosis in patients with acute myocardial infarction. New England Journal of Medicine 296: 898–903, 1977
MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled trial. European Heart Journal 6: 199–226, 1985a
MIAMI Trial Research Group. Other clinical findings and tolerability. American Journal of Cardiology 56: 39G–46G, 1985b
Nielsen JR, Pedersen KE, Dahlström CG, et al. Analgetic treatment in acute myocardial infarction. A controlled clinical comparison of morphine, nicomorphine and pethidine. Acta Medica Scandinavica 215: 349–354, 1984
Pasqualucci V. Advances in the management of cardiac pain. Advances in Pain Research and Therapy 7: 501–504, 1984
Pasqualucci V, Moricca G, Solinas P. Intrathecal morphine for the control of the pain of myocardial infarction. Anaesthesia 36: 68–69, 1981
Richterova A, Herlitz J, Holmberg S, et al. Effects on chest pain. American Journal of Cardiology 53(13): 32D-36D, 1984
Scott ME, Orr R. Effects of diamorphine, methadone, morphine, and pentazocine in patients with suspected acute myocardial infarction. Lancet 1: 1065–1067, 1969
Selwyn AP, Fox KM, Welman E, Jonathan A, Shillingford JP. Electrocardiographic precordial mapping in anterior myocardial infarction. The critical period for interventions as exemplified by methylprednisolone. Circulation 58: 892–897, 1978
Semenkovich CF, Jaffe AS. Adverse effects due to morphine sulfate. Challenge to previous clinical doctrine. American Journal of Medicine 79: 325–330, 1985
Thomas M, Malmcrona R, Fillmore S, Shillingford J. Haemodynamic effects of morphine in patients with acute myocardial infarction, British Heart Journal 27: 863–875, 1965
Thompson PL, Lown B, Nitrous oxide as an analgesic in acute myocardial infarction. Journal of the American Medical Association 325: 924–927, 1976
Todres D. The role of morphine in acute myocardial infarction. American Heart Journal 81: 566–570, 1971
Van der Laarse A, Vermeer F, Hermens WT, Willems GM, de Neef K, et al. Effects of early intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: a randomized trial of 533 patients with acute myocardial infarction. American Heart Journal 112: 672–681, 1986
Waagstein F, Hjalmarson Å. Double-blind study of the effect of cardioselective beta-blockade on chest pain in acute myocardial infarction. Acta Medica Scandinavica 587 (Suppl.): 201–208, 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Herlitz, J. Analgesia in Myocardial Infarction. Drugs 37, 939–944 (1989). https://doi.org/10.2165/00003495-198937060-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198937060-00007